| 标题 |
Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in children with cystic fibrosis aged 2–5 years (TIMBERLINE Trial VX21-121-105): a phase 3, open-label study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Respiratory Medicine 作者:Jonathan H Rayment; Gwyneth Davies; Jonathan M Gaffin; Jordana E Hoppe; Ajay S Kasi; et al 出版日期:2026-09-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)